Romiplostim for Solid Tumors

"The requirements to participate in this clinical trial are having cancer and being between 1 year old up to 21 years old. There is space for 2 patients."

"There are 7 clinical trial sites available, 3 of which are Memorial Sloan Kettering locations in Montvale (Limited Protocol Activities), Basking Ridge (Limited Protocol Activities), and Harrison (Limited Protocol Activitites). 4 other centres are also participating."

"Romiplostim, a medication used to treat certain blood disorders, is the focus of 9 current clinical trials. These studies are being conducted in 23 different countries and across 62 cities. The first Romiplostim trial was completed in 2014 by Amgen. This Phase 2 study had 60 participants. 41 additional trials have been run since then."

"Unfortunately, this particular clinical trial is no longer looking for patients. The study began on December 10th 2020 but was last updated on October 21st 2022. However, there are other active trials you may be eligible for; 2683 cancer trials and 9 Romiplostim studies are currently admitting patients."

"Romiplostim's safety is estimated to be a 2 because, while there are Phase 2 trials underway testing its efficacy, right now there is only data supporting its safety."

"For this particular trial, participants must fall in the age range of 1 year to 21 years old. There are a total of 338 clinical trials for patients under 18 and 2485 for those over 65."

"The most recent update on this particular trial was from 10/21/2022, which means the study is no longer actively recruiting. However, there are 2683 other trials currently looking for cancer patients and 9 trials that involve Romiplostim still enrolling individuals."

"Romiplostim was first studied in 2014 at Memorial Sloan Kettering Bergen. As of now, there have been 41 completed clinical trials with 9 active studies. Currently, a majority of the active romiplostim clinical trials are taking place in Montvale, New york."